Hamm John M. has filed 5 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 3000 shares of CUMBERLAND PHARMACEUTICALS INC ($CPIX) on March 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | CUMBERLAND PHARMACEUTICALS INC | $CPIX | Hamm John M. | VP Chief Financial Officer | A | Options (right to buy) | 3000 | $2.80 | 18,250.0000 | 14,956,627 | 19.67% | 0.02% |
| March 16, 2025 | CUMBERLAND PHARMACEUTICALS INC | $CPIX | Hamm John M. | VP Chief Financial Officer | F | Common Stock | 5930 | $5.46 | 20,073.0000 | 13,952,624 | 22.81% | 0.04% |
| March 17, 2025 | CUMBERLAND PHARMACEUTICALS INC | $CPIX | Hamm John M. | VP Chief Financial Officer | A | Options (right to buy) | 2750 | $5.17 | 15,250.0000 | 13,952,624 | 22.00% | 0.02% |
| March 23, 2024 | CUMBERLAND PHARMACEUTICALS INC | $CPIX | Hamm John M. | VP Chief Financial Officer | F | Common Stock | 445 | $1.81 | 26,003.0000 | 14,121,833 | 1.68% | 0.00% |
| March 25, 2024 | CUMBERLAND PHARMACEUTICALS INC | $CPIX | Hamm John M. | VP Chief Financial Officer | A | Options (right to buy) | 5500 | $1.71 | 12,500.0000 | 14,121,833 | 78.57% | 0.04% |